Prudential Financial Inc Mersana Therapeutics, Inc. Transaction History

Prudential Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$2.16 - $5.94 $37,443 - $102,969	17,335 New	17,335 $77,000
Q1 2023 May 12, 2023	SELL	$4.0 - $7.02 $30,200 - $53,001	-7,550 Reduced 12.86%	51,155 $210,000
Q4 2022 Feb 14, 2023	SELL	$5.65 - $7.86 $248,882 - $346,233	-44,050 Reduced 42.87%	58,705 $0
Q3 2022 Nov 04, 2022	BUY	$4.63 - $8.0 $291,967 - $504,480	63,060 Added 158.86%	102,755 $694,000
Q2 2022 Aug 15, 2022	BUY	$2.84 - $5.0 $83,743 - $147,435	29,487 Added 288.86%	39,695 $183,000
Q4 2019 Feb 11, 2020	BUY	$1.45 - $6.73 $14,801 - $68,699	10,208 New	10,208 $58,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $216M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Prudential Financial Inc with notifications on news.